Salmonella septic arthritis in a patient receiving etanercept: Case report and review of the literature

Military Medicine

Volumn 178, Issue 12, 2013, Pages 1384-1387

  Sky, Karen ^a   Arroyo, Col Ramon A ^b   Collamer, Maj Angelique N ^c  

^a Alaska Va Healthcare System and Regional Office   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c Langley Air Force Base   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; CASE REPORT; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; MICROBIOLOGY; PUBIS SYMPHYSIS; REVIEW; RHEUMATOID ARTHRITIS; SALMONELLOSIS;

AGED; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; PUBIC SYMPHYSIS; RECEPTORS, TUMOR NECROSIS FACTOR; SALMONELLA INFECTIONS;

EID: 84889679354     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-13-00284     Document Type: Article

References (18)

1. Furst DE, Wallis R, Broder M, Beenhouwer DO: Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 2006; 36: 159-167.
2. Sullivan KE: TNF and TNFa inhibitors: mechanisms of action. Pediatr Rheumatol Online J 2004; 2: 7-22.
3. Netea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ: Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-g production and Toll-like receptor 4 expression. Arthritis Rheum 2003; 48: 1853-1857.
4. Dixon WG, Watson K, Lunt M, Hyrich KL: Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Arthritis Rheum 2006; 54: 2368-2376.
5. Katsarolis I, Tsiodras S, Panagopoulos P, et al: Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 2005; 37: 304-305.
6. Makkuni D, Kent R, Watts R, Clunie G: Two cases of serious food-borne infection in patients treated with anti-TNF-a. Are we doing enough to reduce the risk? Rheumatology (Oxford) 2006; 45: 237-238.
7. Rim JY, Tenorio AR: Salmonella septic arthritis in a patient with Crohn's disease on infliximab. Inflamm Bowel Dis 2010; 16(4): 545-547.
8. Oe K, Wada T, Ohno H, Kushida T, Iida H: Salmonella septic arthritis following total knee arthroplasty for rheumatoid arthritis in a patient receiving etanercept. J Orthop Sci 2011; 16(2): 258-262.
9. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO: Gran-ulomatous infectious disease associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38: 1261-1265.
10. Pena-Sagredo J, Farinas M, Perez-Zafrilla B, et al: Non-typhi Salmonella infection in patients with rheumatic disease on TNF-alpha antagonist therapy. Clin Exp Rheumatol 2009; 27: 920-925.
11. Ross JJ: Septic arthritis. Infect Dis Clinc North Am 2005; 19: 799-817.
12. Pegues DA, Miller SI: Salmonella species including Salmonella typhi. In: Principles and Practice of Infectious Disease. Ed 7, Chapter 223. Edited by Mandell. Philadelphia, PA, Churchill Livingstone, 2009.
13. Reddix Jr. RN, Montoya JP, Hurley DL: Late recurrent Salmonella sacroiliac osteomyelitis with psoas abscess in a non-sickle cell adult: case report. Am J Orthop 2007; 36: E5-E6.
14. Smith EL, Martin RP, Matzkin E, Moyer ML: Osteomyelitis of the pubic symphysis. Orthop Blue J 2003; 26; 1233-1235.
15. Ross JJ, Hu LT: Septic arthritis of the pubic symphysis: review of 100 cases. Medicine 2003; 82: 340-345.
16. Gamble K, Dardarian T, Finstein J, Fox E, Sehdev H, Randall C: Osteomyelitis of the pubic symphysis in pregnancy. Obstet Gynecol 2006; 107: 477-481.
17. Miller EA, Ernst JD: Illuminating the black box of TNF action in tuberculous granulomas. J Immunity 2008; 29: 175-177.
18. Mastroeni P, Skepper JN, Hormaeche CE: Effect of anti-tumor necrosis factor alpha on histopathology of primary Salmonella infections. Infect Immun 1995; 63: 3674-3682.